Explore Our Network
Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.
Membership Status
No results found
Member Type
No results found
Type
No results found
Company Size
Currently Seeking Investment
No results found
Country
No results found
Key Technologies
No results found
Expertise Areas
No results found
Digital Health Technologies
No results found
Application Area
No results found
Diagnostics
No results found
Biologics
No results found
Drugs
No results found
Services
No results found
Medical Devices
No results found
Routes of Administration
10.10.10 is a nonprofit organization dedicated to connecting serial entrepreneurs with large organizations and institutions to address wicked problems through proven processes, creating new market-based ventures. It aims to solve complex urban issues like water, infrastructure, health, and social problems by fostering innovation, collaboration, and entrepreneurship.
10x National Security, LLC is dedicated to enhancing national security through the operationalization of new and emerging technologies. The company focuses on creating exceptional user experiences, lowering barriers to technology access, and fostering a culture of radical transparency and collaboration. Their mission is to ensure that future generations benefit from improved national security measures.
12-15 Molecular Diagnostics is an early-stage biotechnology company dedicated to revolutionizing testing and diagnostics with faster, more accurate, and affordable solutions. Their Veralize platform enables early detection of infections and chemical contaminants in fluids, including water, blood, saliva, and more, with results within 10 minutes. The company aims to improve public health, water quality, biodefense, and early disease detection through innovative nanotechnology and partnerships.
149 Medical is dedicated to improving outcomes for premature infants through innovative, life-changing technology. Their primary focus is on reducing morbidity and mortality by providing continuous, real-time monitoring of cerebral blood flow to detect and mitigate risks such as ventricular hemorrhage. Their flagship device, NIRDS1, is a non-invasive intracranial blood flow sensor validated in over 1,000 children, currently in clinical evaluation, and licensed exclusively from Massachusetts General Hospital. The company's mission is to shift the standard of care from traditional, less effective methods to advanced, early detection technologies, ultimately decreasing disabilities and improving long-term health outcomes for the smallest and most vulnerable patients.
1910 Genetics is a biotechnology company focused on advancing small and large molecule drug discovery using a multimodal AI platform integrated with laboratory automation. Their mission is to make undruggable targets a thing of the past, leveraging proprietary data streams and computational technologies to develop novel therapeutics across various disease areas. They collaborate with leading pharma and tech partners, and are backed by prestigious investors. The company emphasizes the integration of biology, AI, and computation to accelerate drug discovery and development.
1928 Diagnostics is a bioinformatics company dedicated to providing fast, secure, and accessible solutions to analyze sequencing data. Their mission is to combat antimicrobial resistance and infectious diseases by delivering innovative, user-friendly, scalable, and reliable bioinformatics tools that support healthcare, research, industry, and clinical applications. They focus on transforming raw sequencing data into actionable insights, enabling faster and more accurate results to address pressing medical challenges globally.
1 Globe Health Institute is dedicated to providing health-related services and information. They focus on science and technology in healthcare, and aim to be a great place to work. Their mission includes offering accessible health solutions and fostering a positive work environment.
1MED is a global Contract Research Organization providing high-quality regulatory, clinical, and post-market services for medical devices, pharmaceuticals, and biotech companies. Established in 2014 and headquartered in Agno, Switzerland, it specializes in supporting innovative medical device development, ensuring compliance with MDR and IVDR regulations, and facilitating product certification and market access. With a focus on innovation, reliability, and comprehensive support across all phases of product lifecycle, 1MED aims to transform complex regulatory processes into efficient pathways for medical technology commercialization.
1Network helps healthcare organizations can identify, develop, and implement the business framework and strategies necessary to speed time-to-market with the assistance. They provide of sales management and commercialization services. They have a vast network of well-connected sales experts, seasoned commercialization consultants, investor relationships, e-learning resources, sales management portals, and more in their arsenal of resources.
1upHealth is a healthcare technology company based in Boston, dedicated to making healthcare data more accessible, shareable, and interoperable through its secure FHIR platform. The company aims to unlock healthcare data, enabling innovation, improving patient care, and supporting regulatory compliance. With a focus on interoperability, 1upHealth provides solutions for payers, providers, digital health, and life sciences, helping them meet CMS requirements and drive better health outcomes.
Provider of a field-deployable powder screening test kit used by first responders to rapidly screen suspicious powders for potential biological agents. Produces self-contained, single-use screening kits that use a protein-detection assay combined with a pH test to provide visual results in minutes. The product has been independently evaluated by national laboratories, holds issued patents, and has received a DHS SAFETY Act designation.
206 Ortho is a company dedicated to developing and commercializing innovative bioresorbable, high-strength materials for bone repair. Their mission is to improve patient care, reduce treatment costs, and transform the orthopedic market by replacing permanent metal implants with resorbable solutions. They focus on creating versatile, nature-mimicking materials that support natural healing and eliminate the need for removal surgeries, aiming to make healthcare more affordable and effective globally.
Audiologist-led hearing-care provider operating a network of paediatric-friendly clinics across Malaysia and Singapore since 2002. Provides diagnostic audiology (adult, pediatric and newborn), hearing-aid selection and fitting, cochlear implant assessment, activation, in-person and remote mapping, auditory rehabilitation, allied therapies (speech-language therapy, counselling, clinical psychology), workplace audiometry and multi-branch operations. Maintains an ISO 9001:2015 quality management system and states compliance with regional personal-data protection and medical-device distribution practices. Publishes patient education content and runs partner promotions and community screening events.
20n Bio is a VC-backed startup dedicated to discovering cyclic peptides for therapeutic use. Based in the Greater Philadelphia region, their mission is to address unmet medical needs by leveraging high-throughput screening and chemical optimization to develop peptide drugs across various therapeutic areas. They have developed a proprietary platform capable of screening trillions of peptides to identify potent candidates and have built partnerships with pharmaceutical and biotech companies.
21st Century Medicine is a research and development company specializing in advanced biopreservation technologies, including hypothermic preservation, cryopreservation, and vitrification. Their mission is to develop innovative solutions for the protection, preservation, transportation, and storage of living systems, with applications spanning from biopharmaceuticals to organ banking and reproductive technologies. They focus on creating custom solutions, developing preservation protocols, and advancing the science of cryobiology to improve patient care and biomedical research.
24sens GmbH is an innovative MedTech startup that combines advanced medical technology with smart textile technology. They develop solutions for continuous 24/7 heart monitoring, especially for early detection of cardiovascular diseases like atrial fibrillation, which is a major cause of strokes. Their products include a textile-based long-term ECG chest strap and related software tools, setting new standards in mobile health monitoring and cardiological diagnostics.
2Blades is a non-profit, agbiotech company dedicated to preventing pre-harvest crop losses by translating scientific discoveries into resilient crop varieties. They support both commercial and smallholder farmers by bridging public and private resources to maximize agricultural innovation success. With over 20 years of experience, they focus on diseases affecting crops like soybean, potato, wheat, and corn, partnering with foundations, companies, and organizations to create a sustainable and productive global food supply.
2N Pharma is an innovative biotech company dedicated to developing treatments for neurodegenerative diseases, with a focus on ALS, Parkinson's disease, and frontotemporal dementia. They utilize a groundbreaking approach targeting mitochondrial dysfunction and lipid metabolism, supported by extensive research and collaborations. Their mission is to find effective cures for these incurable conditions through novel small molecule therapeutics, with ongoing clinical and preclinical development, and active engagement in scientific research, funding, and industry events.
2seventy bio is a company dedicated to outmaneuvering cancer and providing more time for patients. Inspired by the maximum speed of translating human thought into action, the company focuses on scientific expertise in gene therapy and oncology. It was spun out of bluebird bio, Inc., and has a heritage rooted in deep care for patients, thought leadership, and scientific innovation. The company collaborates with Bristol Myers Squibb and other industry partners, and is committed to promoting health equity and access to care. Its mission is to deliver more time to people living with multiple myeloma through innovative therapies, primarily focusing on the drug Abecma.
3-D Med is dedicated to providing innovative medical simulation training solutions. It is the medical simulation division of 3-D Technical Services, which offers models, prototypes, and design assistance to engineering and product development groups. The company's mission is to enhance healthcare education through realistic, cost-effective simulation platforms, including training devices and anatomical models. They also offer custom product development and rental programs for their Minimally Invasive Training Systems (MITS). Their products and training programs are used worldwide, and they collaborate with various partners and distributors to expand their reach.
300K Solutions provides innovative solutions for the stabilization and storage of biological samples at room temperature. Their technology aims to maximize storage capacity, reduce operational costs, and ensure sample security, revolutionizing biobanking and sample preservation. They actively participate in industry events, collaborate with research centers, and have received recognition for their disruptive solutions in biomedicine.
Membership Status
No results found
Member Type
No results found
Type
No results found
Company Size
Currently Seeking Investment
No results found
Country
No results found
Key Technologies
No results found
Expertise Areas
No results found
Digital Health Technologies
No results found
Application Area
No results found
Diagnostics
No results found
Biologics
No results found
Drugs
No results found
Services
No results found
Medical Devices
No results found